Loading BioAtlas...
Loading BioAtlas...
مقایسه شاخبهشاخ مدلهای زیستی، موتورهای داکینگ و پایپلاینهای محاسباتی. فیلتر بر اساس مدل دسترسی، مصرف پردازشی و دستهبندی جهت اخذ تصمیم دقیق در کمتر از یک دقیقه.
| مشخصه | ＋ افزودن ابزار | |
|---|---|---|
| Category | Drug Discovery & Chemistry | — |
| Subcategory | End-to-End AI Drug Discovery Platform | — |
| Company | Insilico Medicine | — |
| Access mode | Commercial Subscription & Co-Development | — |
| Licence conditions | Proprietary commercial software | — |
| Compute requirements | Cloud SaaS with enterprise security compliance | — |
| Biological application | Fibrosis, oncology, immunology, and age-related disease drug discovery | — |
| Research workflow | Disease multi-omics data -> novel target selection -> generative chemistry -> candidate synthesis | — |
| Evidence level | Clinical-stage pipeline with published experimental and clinical validation (Nature Biotech 2024) | — |
| Commercial eligibility | Commercial enterprise licensing and drug discovery partnerships | — |
| Price | Enterprise partnership — contact vendor | — |
| Availability ⓘ | Globally available for biopharma partners | — |
| Features | PandaOmics for multi-omics target identification and biological aging biomarker analysis, Chemistry42 generative chemistry platform with 42 distinct generative algorithms, Demonstrated progression of novel targets and molecules into Phase II clinical trials (e.g. ISM001-055 for IPF), High-throughput synthetic accessibility and automated ADMET filtering | — |
| Entry type | Commercial Platform | — |
| AI role | End-to-End Generative Chemistry | — |
| Input data | ثبتنشده | — |
| Output data | ثبتنشده | — |
| Validation | ثبتنشده | — |
| Type | End-to-end generative AI drug platform | — |
| Intended use | ثبتنشده | — |
| Compatibility | ثبتنشده | — |
| Manufacturer | Insilico Medicine | — |
| Integration evidence | https://insilico.com/platform | — |
| Laboratory handoff | Compounds synthesized in automated robotic labs for biochemical IC50 testing | — |